1 / 6

Cancer Testing/Screening Market Research Report | Market Intel Reports

Cancer is a group of diseases, which involves the abnormal cell growth with the ability or the potential to spread to the other parts of the body. These cells form a neoplasm, where neoplasm or tumor is a group of cells that will undergo an unregulated growth.<br>

roopaP
Télécharger la présentation

Cancer Testing/Screening Market Research Report | Market Intel Reports

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer Testing/Screening Market Research Report | Market Intel Reports Published on – 15 March, 2016 | Number of pages : 156 Single User Price: $ 5250 “Cancer Testing/Screening Market”

  2. Cancer is a group of diseases, which involves the abnormal cell growth with the ability or the potential to spread to the other parts of the body. These cells form a neoplasm, where neoplasm or tumor is a group of cells that will undergo an unregulated growth. There are over 100 different known cancers that affect humans. The cancer screening or cancer testing, targets to detect the cancer before symptoms appear and also before it starts to spread throughout the body.

  3. Screening tests must be accurate and effectively appropriate in order to perform the necessary diagnosis. The most common sites of cancer among men are lung, prostate, colon, rectum, stomach and liver. The most common sites of cancer among women are breast, colon, rectum, lung, cervix and stomach. CLICK HERE TO CHECK COMPLETE REPORT

  4. Though the cost of diagnosis is one of the main constraints, government support and indigenous technologies from countries such China, India, and Japan is helping the market penetration. A simple blood test could be on the way to replacing the biopsy as the gold standard for detecting cancer, saving lives and money, according to researchers in the U.K. In their study, carried out on known or suspected primary or secondary lung cancer who were about to undergo surgery, the blood test was accurate in predicting the presence of cancer cells in nearly 70% of cases. AVAIL MORE INFORMATION FROM SAMPLE BROCHURE OF REPORT

  5. About Us: MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers. MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients. MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the “Cancer Testing/Screening Market”. MAKE A ENQUIRY BEFORE BUYING

  6. Cancer Testing/Screening Market Research Report | Market Intel Reports A detailed qualitative analysis of the factors responsible for driving and restraining growth of “Cancer Testing/Screening Market Research Report | Market Intel Reports” and future opportunities are provided in the report. Contact: 1-302-261-5343 pr@marketintelreports.com www.marketintelreports.com CLICK HERE TO PROCURE THIS REPORT

More Related